PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1383331
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1383331
Human Microbiome Market Forecasts to 2030 - Global Analysis By Product (Medical Foods, Prebiotics, Probiotics, Symboitics and Other Products), Disease, Type, Application and By Geography
According to Stratistics MRC, the Global Human Microbiome Market is accounted for $0.8 billion in 2023 and is expected to reach $6.3 billion by 2030 growing at a CAGR of 34.1% during the forecast period. The term "Human Microbiomes Market" defines the area of biotechnology and healthcare that focuses on the thorough study, analysis, and commercial applications of the human microbiome, which is the enormous and diverse community of microorganisms that exists both inside and outside the human body. To comprehend the symbiotic interaction between the human body and its resident microorganisms, it comprises a variety of fields, including research, diagnostics, treatments, and customized medicine.
According to the American Cancer Society, 2022 estimates, there are about 1,918,030 new cases of cancer will be reported in the United States in 2022. Additionally, according to the Globocan 2020 statistics, there are 274,364 new cases of cancer and is expected to reach 400,564 new cases by 2040.
Market Dynamics:
Driver:
Research advances in the microbiome
An enormous shift has occurred in the comprehension of the human microbiome's involvement in human health and disease as a result of the substantial advancements made in the investigation of it over the past few decades. Additionally, the tremendous community of microorganisms that reside inside the human body has been thoroughly analyzed and characterized because of high-throughput sequencing methods and powerful bioinformatics tools.
Restraint:
Regulatory barriers
The lack of transparent and uniform regulatory processes for microbiome-based products and treatments is one of the main problems. The absence of simple and uniform regulatory frameworks for microbiome-based products and treatments may limit market expansion and increase entry hurdles. However, the variety of microbial communities and the dynamic nature of the human microbiome present difficulties for regulatory authorities when evaluating products' safety and efficacy.
Opportunity:
Chronic disease prevalence is on the rise
Globally, chronic illnesses such as obesity, diabetes, inflammatory bowel diseases, and autoimmune disorders are becoming more prevalent. As a result, in order to better understand and manage these chronic diseases, medical professionals and academics are exploring microbiome-based therapies. Additionally, the restoration of microbial equilibrium among individuals with chronic illnesses involves a number of developing methods, including probiotics, fecal microbiota transplantation (FMT), and microbiome regulation.
Threat:
Research and development expenses
In order to fully comprehend the complexity of the human microbiome as well as develop products and eliminates that are based on it, the field of microbiome research requires significant investments in research and development (R&D). The creation of microbiome therapies like probiotics and prebiotics, as well as data analysis, clinical trials, and microbiome sequencing, are all included in these expenditures. However, the variety of products and treatments available may be hampered by the high cost of R&D, which may prevent smaller businesses and startups from entering the market.
COVID-19 Impact:
Clinical trial research has been significantly hampered worldwide by the COVID-19 epidemic. Given that studies usually include poor people who are most in danger from COVID-19 exposure, this is very important. Similarly, COVID-19 has had a detrimental effect and might still have one on the operations of other companies, including their preclinical research and clinical testing of microbiome-based drugs and diagnostic instruments.
The probiotics segment is expected to be the largest during the forecast period
The segment for probiotics is anticipated to be the largest during the forecast period. Probiotics are living microorganisms that, when administered to a host in sufficient proportions, improve or maintain the host's overall health by restoring or maintaining their intestinal microbiome. Due to their significance in promoting immune health, boosting digestion, and potentially affecting a number of different elements of general wellbeing, they have grown tremendously popular. Furthermore, with an increasing emphasis on preventive health and wellness, the probiotics sector is anticipated to develop as customers look for microbiome-friendly remedies to their medical issues.
The diagnostics segment is expected to have the highest CAGR during the forecast period
Due to the growing awareness of the crucial role played by the human microbiome in health and illness, the diagnostics segment is anticipated to have the highest growth rate throughout the projection period. Microbiome diagnostics can offer a deeper comprehension of the microbial populations within the body due to developments in sequencing technologies and bioinformatics, enabling personalized and precise therapy. Moreover, microbiome diagnostics are also becoming more popular in healthcare due to their potential to support early disease detection, guide individualized treatment strategies, and assess the success of interventions.
Region with largest share:
North America held the largest share due to an established network of healthcare facilities, greater investment from major firms in developing more advanced technology, accelerating the process of creating new drugs, and a rise in research efforts in this field. Additionally, human microbiome treatments are getting more attention, lifestyle ailments are becoming more prevalent, and next-generation sequencing and the human microbiome are experiencing more technological advancements. These factors are all contributing to the market's growth in the region.
Region with highest CAGR:
Due to growing consumer interest in probiotics, prebiotics, and microbiome-focused products, the Asia-Pacific area is predicted to experience profitable growth. This is due to digestion, nutritional wellness, and the importance of the microbiome in overall well-being which are becoming more widely recognized. Additionally, the Asia Pacific area has experienced a rise in research and development activities in the field of microbiome science, especially in nations like China, Japan, and South Korea that have made significant investments in biotechnology and the life sciences.
Key players in the market
Some of the key players in Human Microbiome market include: Seres Therapeutics, Second Genome Inc., Osel Inc., Exeliom Biosciences SAS, Ginkgo Bioworks, Finch Therapeutics Group Inc., Evelo Biosciences Inc, DuPont, Axial Biotherapeutics, Inc. and Astarte Medical.
Key Developments:
In January 2023, Genetic Analysis AS, a research driven diagnostic company that focuses on innovative diagnostic solutions with microbiota analysis, entered into an agreement with Microbiome Research Pvt. Ltd., a India-based microbiome company, for launching a test service portfolio based on the GA-map Dysbiosis Test, and thus, making it the first CE-IVD marked standardized gut microbiome test.
In May 2022, 4D Pharma, a global pharmaceutical company that develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis, announced clinical trial for MRx0518 with combination bavencio, a PD - L1 blocking antibody indicated for the treatment of urothelial cancer
Products Covered:
- Medical Foods
- Prebiotics
- Probiotics
- Symboitics
- Other Products
Diseases Covered:
- Metabolic
- Endocrine
- Infectious
Types Covered:
- Cancer
- Metabolic and Gastrointestinal Disorders
- Autoimmune Disorder
- Obesity
- Other Types
Applications Covered:
- Diagnostics
- Therapeutics
- Other Applications
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 Application Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Human Microbiome Market, By Product
- 5.1 Introduction
- 5.2 Medical Foods
- 5.3 Prebiotics
- 5.4 Probiotics
- 5.5 Symboitics
- 5.6 Other Products
6 Global Human Microbiome Market, By Disease
- 6.1 Introduction
- 6.2 Metabolic
- 6.3 Endocrine
- 6.4 Infectious
7 Global Human Microbiome Market, By Type
- 7.1 Introduction
- 7.2 Cancer
- 7.3 Metabolic and Gastrointestinal Disorders
- 7.4 Autoimmune Disorder
- 7.5 Obesity
- 7.6 Other Types
8 Global Human Microbiome Market, By Application
- 8.1 Introduction
- 8.2 Diagnostics
- 8.3 Therapeutics
- 8.4 Other Applications
9 Global Human Microbiome Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Seres Therapeutics
- 11.2 Second Genome Inc.
- 11.3 Osel Inc.
- 11.4 Exeliom Biosciences SAS
- 11.5 Ginkgo Bioworks
- 11.6 Finch Therapeutics Group Inc.
- 11.7 Evelo Biosciences Inc
- 11.8 DuPont
- 11.9 Axial Biotherapeutics, Inc.
- 11.10 Astarte Medical
List of Tables
- Table 1 Global Human Microbiome Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
- Table 3 Global Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
- Table 4 Global Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
- Table 5 Global Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
- Table 6 Global Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
- Table 7 Global Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
- Table 8 Global Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
- Table 9 Global Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
- Table 10 Global Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
- Table 11 Global Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
- Table 12 Global Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
- Table 13 Global Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
- Table 14 Global Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
- Table 15 Global Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
- Table 16 Global Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
- Table 17 Global Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
- Table 18 Global Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
- Table 19 Global Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
- Table 20 Global Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
- Table 21 Global Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 22 North America Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
- Table 23 North America Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
- Table 24 North America Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
- Table 25 North America Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
- Table 26 North America Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
- Table 27 North America Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
- Table 28 North America Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
- Table 29 North America Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
- Table 30 North America Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
- Table 31 North America Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
- Table 32 North America Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
- Table 33 North America Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
- Table 34 North America Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
- Table 35 North America Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
- Table 36 North America Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
- Table 37 North America Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
- Table 38 North America Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
- Table 39 North America Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
- Table 40 North America Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
- Table 41 North America Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
- Table 42 North America Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 43 Europe Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
- Table 44 Europe Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
- Table 45 Europe Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
- Table 46 Europe Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
- Table 47 Europe Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
- Table 48 Europe Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
- Table 49 Europe Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
- Table 50 Europe Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
- Table 51 Europe Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
- Table 52 Europe Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
- Table 53 Europe Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
- Table 54 Europe Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
- Table 55 Europe Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
- Table 56 Europe Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
- Table 57 Europe Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
- Table 58 Europe Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
- Table 59 Europe Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
- Table 60 Europe Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
- Table 61 Europe Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
- Table 62 Europe Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
- Table 63 Europe Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 64 Asia Pacific Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
- Table 65 Asia Pacific Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
- Table 66 Asia Pacific Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
- Table 67 Asia Pacific Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
- Table 68 Asia Pacific Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
- Table 69 Asia Pacific Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
- Table 70 Asia Pacific Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
- Table 71 Asia Pacific Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
- Table 72 Asia Pacific Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
- Table 73 Asia Pacific Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
- Table 74 Asia Pacific Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
- Table 75 Asia Pacific Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
- Table 76 Asia Pacific Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
- Table 77 Asia Pacific Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
- Table 78 Asia Pacific Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
- Table 79 Asia Pacific Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
- Table 80 Asia Pacific Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
- Table 81 Asia Pacific Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
- Table 82 Asia Pacific Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
- Table 83 Asia Pacific Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
- Table 84 Asia Pacific Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 85 South America Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
- Table 86 South America Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
- Table 87 South America Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
- Table 88 South America Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
- Table 89 South America Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
- Table 90 South America Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
- Table 91 South America Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
- Table 92 South America Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
- Table 93 South America Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
- Table 94 South America Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
- Table 95 South America Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
- Table 96 South America Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
- Table 97 South America Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
- Table 98 South America Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
- Table 99 South America Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
- Table 100 South America Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
- Table 101 South America Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
- Table 102 South America Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
- Table 103 South America Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
- Table 104 South America Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
- Table 105 South America Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 106 Middle East & Africa Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
- Table 107 Middle East & Africa Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
- Table 108 Middle East & Africa Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
- Table 109 Middle East & Africa Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
- Table 110 Middle East & Africa Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
- Table 111 Middle East & Africa Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
- Table 112 Middle East & Africa Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
- Table 113 Middle East & Africa Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
- Table 114 Middle East & Africa Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
- Table 115 Middle East & Africa Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
- Table 116 Middle East & Africa Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
- Table 117 Middle East & Africa Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
- Table 118 Middle East & Africa Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
- Table 119 Middle East & Africa Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
- Table 120 Middle East & Africa Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
- Table 121 Middle East & Africa Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
- Table 122 Middle East & Africa Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
- Table 123 Middle East & Africa Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
- Table 124 Middle East & Africa Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
- Table 125 Middle East & Africa Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
- Table 126 Middle East & Africa Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
